fbpx
QQQ
-0.34
329.37
-0.1%
DIA
+ 0.58
341.76
+ 0.17%
SPY
-0.16
415.95
-0.04%
TLT
-0.23
139.92
-0.16%
GLD
+ 1.95
165.36
+ 1.17%

Why CRISPR Therapeutics Is Trading Higher Today

April 21, 2021 11:13 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

The Price And Volume Action In CRISPR Therapeutics's Stock Today

CRISPR Therapeutics's (NASDAQ:CRSP) stock has been rising Wednesday, up 4.14% to a price of $128.12. The stock's current volume for the day is 811.58 thousand, which is approximately 51.14% of its previous 30-day average volume of 1.59 million.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: CRISPR Therapeutics shares are trading higher after Jefferies upgraded the stock from Hold to Buy and announced a price target of $172 per share.

Further Analysis of Recent Price Action

The moving average price of the stock over the past 50 days was $129.36 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $220.2 and as low as $46.84.

If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.

Posted-In:

Movers Trading Ideas

Related Articles

Why CRISPR Therapeutics Stock Is Trading Higher Today

CRISPR Therapeutics (NASDAQ: CRSP) shares are trading higher after the company and its partner Vertex Pharmaceuticals announced the EMA granted Priority Medicines designation to CTX001 for the treatment of transfusion-dependent beta thalassemia. read more

Why Voyager Therapeutics, uniQure, Axsome, Reviva Pharma and Crispr Are Moving Today

Voyager Therapeutics, Inc. (NASDAQ: VYGR), uniQure N.V. (NASDAQ: QURE), Axsome Therapeutics, Inc. read more

46 Biggest Movers From Yesterday

Gainers read more

31 Stocks Moving In Tuesday's Mid-Day Session

Gainers MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) gained 20.8% to $5.32 after dropping more than 10% on Monday. read more